medigraphic.com
ISSN 1561-3070 (Electronic)

2012, Number s1

<< Back Next >>

Rev Cub Oftal 2012; 25 (s1)

Needle revision and use of Mitomycin-C to manage encapsulated filtering blebs

Fumero GF, Vidal CM, Fernández AL, Piloto DI, Obret MI, Pérez CE

Language: Spanish
References: 26
Page:
PDF size: 91.95 Kb.


ABSTRACT

Trabeculectomy is the surgical treatment of choice for many patients with glaucoma. The most common cause of failure during the first trimester after trabeculectomy is encapsulated bleb. Generally, that results from scarring in the subconjunctival space with a resultant intrableb fibrosis and the development of a failed bleb, for example in traumatic glaucoma. Needling bleb revision with mitomycin-C appears to be an effective and relatively safe way to revive the function of the filtration surgery. This was the case report of a patient whose aqueous humor flow was reestablished with this treatment.


REFERENCES

  1. McIlraith I, Strasfeld M, Colev G, Hutnik CML. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. Glaucoma J. 2006;15(2):124-30.

  2. Zarei R, Shahhosseini S, Faragee-Oskouee G. Needle revision with Mitomycin-c in encapsulated Blebs. Acta Medica Iranica. 2008;46(4):295-8.

  3. Ruderman JM. Revising the failing filtration bleb. Techniques in Ophthalmology. 2005;3(3):133-7.

  4. Eid TM, Spaeth GL. The glaucoma. 2da. ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 285-6.

  5. Wright KW. Textbook of ophthalmology. Baltimore: Williams & Wilkins; 1997. p. 640-1.

  6. Sharmila R, Prashanth R, Krishnadas R. Needle revision of failing filtering blebs may spare patients and physicians another trip to the OR. AIOC proceeding: Glaucoma session II; 2008. p. 2713 [citado 5 abril 2011]. Disponible en: http://www.aios.org/proceed08/papers/GLU-II/Glu-II8.pdf

  7. Perucho-Martínez S, Gutiérrez-Díaz E, Montero-Rodríguez M, Mencía-Gutiérrez E, Lago-Llinás MD. Repermeabilización mediante revisión con aguja de ampollas de filtración con fracaso tardío tras cirugía de glaucoma. Arch Soc Esp Oftalmol. 2006 [citado: 5 de abril de 2011];81(9). Disponible en: http://scielo.isciii.es/scielo.php?pid=S0365-66912006000900006&script=sci_arttext

  8. Boyd BF. Últimas innovaciones en el glaucoma. Etiología, diagnóstico y tratamiento. Panamá: Highlights of Ophthalmology; 2002.

  9. Durak I, Ozbek Z, Yaman A, Soylev M, Cingil G. The role of needle revision and 5-fluorouracil application over the filtration site in the management of bleb failure after trabeculectomy: a prospective study. Doc Ophthalmol. 2003;106(2):189-3.

  10. Fine LC, Chen TC, Grosskreutz CL, Pasquale LR. Management and prevention of thin, cystic blebs. Int Ophthalmol Clin. 2004;44(1):29-42.

  11. Ung CT, Von Lany H, Claridge KG. Late bleb needling. Br J Ophthalmol. 2003; 87(11):1430-1.

  12. Guy J, Ben S, Glovinsky Y. Needle revision of failed filtering blebs augmented with subconjunctival injection of mitomycin C. Ophthalmic Surg Lasers Imaging. 2003;34(2):94-9.

  13. González Rodríguez MJ. I Curso teórico práctico de cirugía filtrante no perforante en glaucoma. [Internet]. Vigo: Centro de Cirugía de Mínima Invasión Jesús Usón Cáceres; 2008 [4 feb 2012]. Disponible en: http://www.ccmijesususon.com/es/noticias/141-i-curso-teo-prico-de-cirugfiltrante-no-perforante-en-glaucoma.html

  14. Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of Molteno glaucoma drainage devices. Ophthalmology. 1996;103(2):299-305.

  15. Broadway DC, Jester M, Schulzer M, Douglas GR. Survival analysis for success of Molteno tube implants. Br J Ophthalmol. 2001;85(6):689-95.

  16. Jampel HD, Musch DC, Gillespie BW, Collaborative Initial Glaucoma Treatment Study Group. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140(1):16-22.

  17. Lewis TL. Primary care of the glaucomas. New York: McGraw-Hill; 2001.

  18. Ewing RH, Stamper RL. Needle revision with and without 5-fluorouracil for the treatment of failed filtering blebs. Am J Ophthalmol. 1990;110(3):254-9.

  19. MaestrinH A, Cronemberger S, Matoso HD. Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium. Ophthalmology. 2011;118(4):755-62.

  20. Hawkins AS, Flanagan JK, Brown SV. Predictors for success of needle revision of failing filtration blebs. Ophthalmology. 2002;109(4):781-5.

  21. Mardelli PG, Lederer CM, Murray PL. Slit lamp needle revision of failed filtering blebs using MMC. Ophthamology. 1996;103(11):1946-54

  22. Kahook, MY. Needle bleb revision with bevacizumab. Techniques in Ophthalmology. 2008;6(4):111-3.

  23. Kahook MY, Schuman JS, Noecker RJ. Needle bleb revision of encapsulated filtering bleb with bevacizumab. Ophthalmic Surg Lasers Imaging. 2006;37(2):148-50.

  24. McDermott ML, Wang J, Shin DH. Mitomycin and the human corneal endothelium. Arch Ophthalmol. 1994;112(4):533-7.

  25. Anand N, Khan A. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report. Glaucoma J. 2009;18(7):513-20.

  26. Rotchford AP, King AJ. Needling revision of trabeculectomies bleb morphology and longterm survival. Ophthalmology. 2008;115(7):1148-53.




2020     |     www.medigraphic.com